Financial Info

Financial Highlights  |  Ratios

Valuation P/E 18.55x   P/S 1.06x   P/B 2.48x   EPS 1816.42	Financial Strength Quick Ratio (MRQ) 0.55x   Current Ratio (MRQ) 1.10x   Total Debt/Equity (MRQ) 1.53x   Total Debt/Assets (MRQ) 0.60x	Operating Ratios Assets Turnover (TTM) 0.85x   Inventory Turnover (TTM) 1.81x   Receivables Turnover (TTM) 2.97x
Profitability Gross Margin (TTM) 29.61%   Operating Margin (TTM) 7.44%   EBIT Margin (TTM) 7.47%   Profit Margin (TTM) 6.01%	Management Effectiveness ROA (TTM) 5.13%   ROE (TTM) 13.04%   ROIC (TTM) 20.68%	Growth Rate Diluted EPS Growth (TTM) -16.15%   Sales Growth (TTM) 5.54%   Profit Growth (TTM) -3.58%   Asset Growth (TTM) 10.05%

MRQ: Most Recent Quarter    TTM: Trailing 12 Mon.    LFY: Last Fiscal Year

Compared to other companies in the same field, Agimexpharm Pharmaceutical Joint Stock Company is a small-scaled company in terms of assets, annual revenue, and owner equity. In terms of ROE, it ranks at number 4 out of 10 companies. The company has its own competitive edge in the market thanks...